Find clinical trials for Kidney Disease in Ann Arbor, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Kidney Disease trials near Ann Arbor, MI, USA:
This is purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease...
Phase 2
Dearborn, Michigan, United States and 55 other locations
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...
Phase 2
Shelby, Michigan, United States and 23 other locations
is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal recessive polycystic kidney...
Phase 3
Ann Arbor, Michigan, United States and 17 other locations
The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease...
Phase 2
Roseville, Michigan, United States and 71 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Ann Arbor, Michigan, United States and 326 other locations
Primary Objectives:To evaluate the safety (compared to iron sucrose) and efficacy of ferumoxytol in pediatric CKD subjects with iron deficiency anemi...
Phase 3
Detroit, Michigan, United States and 20 other locations
Additionally, the study investigates the non-interventional feasibility of home measurement of serum creatinine in participants with diabetic kidney...
Phase 1
Ann Arbor, Michigan, United States and 4 other locations
This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific t ...
Phase 2
Pontiac, Michigan, United States and 162 other locations
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...
Phase 3
Ann Arbor, Michigan, United States and 93 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Troy, Michigan, United States and 295 other locations
Clinical trials
Research sites
Resources
Legal